Welcome to EECP NOW, a triennial publication dedicated to the exciting world of enhanced external counterpulsation. In this second issue we take a look at the versatility of EECP treatment, answer frequently asked questions about EECP, and offer an annotated case presentation of a patient...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1628571682657{padding-top: 30px !important;padding-bottom: 50px !important;}" z_index=""][vc_column][vc_column_text]Enhanced External Counterpulsation[/vc_column_text][/vc_column][/vc_row]...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=".vc_custom_1628786885952{padding-bottom: 30px !important;}"]EECP NOW is a triannual print and digital publication dedicated to raising awareness of EECP therapy by exploring the many facets of this dynamic, underutilized treatment.   Please enquire via our Contact page if you would like to...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Jose Caceres MD1 | Patricia Atal MD1 | Rohit Arora MD2 | Derek Yee Editor1 PDF LINK[/vc_column_text][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1614056551731{padding-top: 40px !important;padding-bottom: 40px !important;}" z_index=""][vc_column][vc_column_text] 1. WHAT IS KNOWN AND OBJECTIVES Coronary artery disease (CAD) is...

In the United States alone, more than 2.5 million patients with symptomatic coronary heart disease (CHD) are not amenable to percutaneous coronary intervention -angioplasty with stent deployment- or coronary artery bypass grafting (CABG) surgery because of unsuitable coronary anatomy, multipleprevious revascularization attempts, age, additional comorbid...

In the United States alone, more than 2.5 million patients with symptomatic coronary heart disease (CHD) are not amenable to percutaneous coronary intervention (angioplasty with stent deployment) or coronary artery bypass grafting (CABG) surgery because of unsuitable coronary anatomy, multiple previous revascularization attempts, age, additional...

Heart disease is the number one cause of death for both men and women in the United States. An estimated 83.6 million American adults have one or more types of Cardiovascular disorders. Of these, 42.2 million are estimated to be...

EECP® is a non-invasive treatment for patients who are suffering from chest pain, shortness of breath, weakness, fatigue, pain in the jaw or back or fullness in the chest; all are possible signs of angina. EECP® treatment can reduce or eliminate the frequency and intensity of...

Make an Appointment. Call (714)816-9856 Do you have congestive heart failure or suffer from chronic chest pain? For people with angina or heart failure, even simple activities — such as going to the mailbox or walking the dog — can be challenging. If you have these symptoms,...

When patients have angina, their bodies are telling them that their heart is not receiving enough oxygen. A treatment, in harmony with patients' heart, can improve circulation to the heart muscle. After EECP® treatment, patients may find that they: walk farther are more active have fewer attacks of...